Fracture Monitor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-03

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thirty-seven patients diagnosed with femoral fracture to be treated with a compatible plate will be enrolled for this multicenter prospective interventional study. The Fracture Monitor T1 will be attached to the locking plate during osteosynthesis. Prior to discharge, it will be connected to an app installed either on the patients' smartphone or on the smartphone provided by the sponsor. The device will continuously collect and process data, which can automatically be downloaded via Bluetooth through the smartphone app and transferred in encrypted form to a dedicated cloud server. The smartphones will be equipped with a basic app version with rudimentary user interface that has no data visualization function. During the rehabilitation phase, data collected by the device will not be accessible to the surgeon nor the patient to ensure that no therapeutic decision will be made based on the acquired data. Every patient is treated as per standard of care.

The primary objective of the study is to collect safety information of the Fracture Monitor T1. The secondary objectives are to collect information on device performance, device handling, and usability.

All adverse events (AEs) and serious AEs (SAEs) will be recorded during the study. These will be reviewed and evaluated for their potential relationship to the device.

All patients will be followed up for 6 months after the surgery according to the local standard of care. Given that the removal of the Fracture Monitor T1 may occur beyond 6 months, a safety follow-up will take place at the time point when the Fracture Monitor T1 is removed as per the instructions for use if it has not been removed within the 6 months.

The results will be compiled into a clinical evaluation report to be submitted as part of the technical documentation for the conformity assessment procedure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Locking Plates for Distal Femur Fractures - a Multicenter Case Review

NCT04008940

Distal Femur Fracture

COMPLETED

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

NCT04113044

Hip Fractures Tibial Fractures Ankle Fractures +2 more

RECRUITING

Focused Registry SmartFix

NCT02094209

Fracture of Shaft of Tibia

COMPLETED

Identifying Risk Factors for Falls in Patients With a High Risk of Fracture Using Connected Insoles (FeetMe Monitor® Device)

NCT05155761

Fall Fall Patients Osteoporosis

UNKNOWN NA

Treatment of Acetabular Posterior Wall Fracture With Anatomical Locking Plate

NCT01437150

Fracture of Acetabulum

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Multicenter prospective interventional clinical investigation

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fracture Monitor T1 (implantable device class III)

Group Type OTHER

Fracture Monitor (implantable device class III)

Intervention Type DEVICE

Femoral fracture fixation (bridge plating aiming at secondary bone healing) using a locking plate with an attached investigational Fracture Monitor T1.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fracture Monitor (implantable device class III)

Femoral fracture fixation (bridge plating aiming at secondary bone healing) using a locking plate with an attached investigational Fracture Monitor T1.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* Closed growth plates at time of injury
* Femoral fracture requiring osteosynthesis and treated with one of the following plates:

* DePuy Synthes LCP® 4.5/5, Broad
* DePuy Synthes LCP® 4.5/5, Broad Curved
* DePuy Synthes LCP® Condylar Plate 4.5/5.0
* DePuy Synthes VA-LCP® Condylar Plate 4.5/5.0
* DePuy Synthes LCP® Distal Femur
* DePuy Synthes LCP® Proximal Femoral Plate 4.5/5.0
* DePuy Synthes LCP® Proximal Femur Hook Plate
* 41medical AG, Biphasic Plate DF
* ASA score 1-3
* Full weight-bearing capacity prior to the injury
* The patient is foreseen to be capable of postoperative weight bearing of at least 15 kg
* Willingness to undergo an additional surgery to remove the Fracture Monitor T1 if its removal is not done together with the fixation plate within two years according to standard of care
* Ability to provide written informed consent

Exclusion Criteria

* Concomitant fractures in the contralateral leg
* Electromagnetic hypersensitivity
* Implanted electromagnetic bone stimulators
* Pregnancy (determined by pregnancy test)
* Prisoner
* Known history of substance abuse (eg, recreational drugs and alcohol) that would preclude reliable assessments
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present clinical investigation

* Use of compression lag screw across fracture fragment
* Compression osteosynthesis
* Precontouring of implant at the area of the attachment of Fracture Monitor T1
* Double-plating technique
* Soft-tissue coverage \> 6 cm above the data logger
* Concurrent use of intramedullary nail
* Patients foreseen to require magnetic resonance imaging scanning at any part of the body or shockwave therapy at the proximity of the Fracture Monitor T1
* Fracture Monitor T1 not functional according to the instruction for use (IFU, section 24, A) and no functional replacement implant available

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No